Hikma Pharmaceuticals PLC HIK shares were unchanged Tuesday at £19.11, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index UKX rising 0.48% to ...

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of ...

This systematic review looked at 26 studies of buprenorphine-precipitated withdrawal, including 5 randomized trials, all conducted between 2002 and 2023 and with a total sample size of 4,497 patients.

Patients who received higher doses of buprenorphine, a common medication used to alleviate opioid withdrawal and cravings, were less likely to be hospitalized and less likely to discontinue ...

On August 22, 2024, Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals, PLC (collectively Hikma), filed a petition for rehearing en banc, asking the US Court of Appeals for the Federal ...

When evaluating the comparative effectiveness of naltrexone vs buprenorphine, extended-release naltrexone (XR-NTX) and sublingual buprenorphine (SL-BUP) are similarly effective for reducing ...